4.8 Article

The Alarmin Interleukin-33 Drives Protective Antiviral CD8+ T Cell Responses

Journal

SCIENCE
Volume 335, Issue 6071, Pages 984-989

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1215418

Keywords

-

Funding

  1. Bundesministerium fur Bildung und Forschung (BMBF)-FORSYS
  2. National Health and Medical Research Council
  3. German Research Foundation [GRK1121, SFB618, SFB650]
  4. Science Foundation Ireland
  5. Program for Improvement of Research Environment for Young Researchers
  6. Japanese Ministry of Education, Culture, Sports, Science and Technology
  7. Japan Science and Technology Agency, PRESTO
  8. BMBF (NGFNplus) [FKZ PIM-01GS0802-3]
  9. Wilhelm Sander-Stiftung
  10. Volkswagen Foundation
  11. Fondation Leenaards
  12. European Community
  13. Swiss National Science Foundation
  14. Grants-in-Aid for Scientific Research [21390303, 23390262] Funding Source: KAKEN

Ask authors/readers for more resources

Pathogen-associated molecular patterns decisively influence antiviral immune responses, whereas the contribution of endogenous signals of tissue damage, also known as damage-associated molecular patterns or alarmins, remains ill defined. We show that interleukin-33 (IL-33), an alarmin released from necrotic cells, is necessary for potent CD8(+) T cell (CTL) responses to replicating, prototypic RNA and DNA viruses in mice. IL-33 signaled through its receptor on activated CTLs, enhanced clonal expansion in a CTL-intrinsic fashion, determined plurifunctional effector cell differentiation, and was necessary for virus control. Moreover, recombinant IL-33 augmented vaccine-induced CTL responses. Radio-resistant cells of the splenic T cell zone produced IL-33, and efficient CTL responses required IL-33 from radio-resistant cells but not from hematopoietic cells. Thus, alarmin release by radio-resistant cells orchestrates protective antiviral CTL responses.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available